President Trump’s recently announced plan to lower prescription drug prices could benefit consumers in the short run, but it may end up hurting new drug development, experts say.
President Trump’s recently announced plan to lower prescription drug prices could benefit consumers in the short run, but it may end up hurting new drug development, experts say.
The Joseph H. Lauder Institute
256 South 37th street
2nd Floor
Philadelphia, PA 19104-6330